For your patients
The results of a quality improvement initiative at Rutgers New Jersey University Hospital, Newark, focused on increasing goals of care conversations in older patients with low pre-injury palliative performance scale scores.
Seeking input from a patient’s oncologist is key when managing common clinical scenarios in advanced cancer patients.
The results of a quality improvement initiative in the intensive care unit at the Hospital for Sick Children, Toronto, ON, focused on reducing inappropriate prophylactic antibiotic use in neonatal patients.
Describes the aim and structure of the OPT-IN trial, which was developed to address the high recurrence rates seen in patients with presumably localized disease after re-resection of incidentally diagnosed gallbladder cancer.
More in this category
- Reducing returns to the operating room
- Neoadjuvant immunotherapy: Results in melanoma show promise and pave the way for other solid tumors
- Australian hospital calls in the COPS to improve care of older patients
- Trials explore whether endocrine therapy can delay or avert surgery in low-risk DCIS
- Hospital aims to stop the clot in neurosurgery
- Preoperative radiotherapy for retroperitoneal sarcoma: Where do we go from here?
- Pediatric surgeons and gastroenterologists collaborate with outpatient community services to streamline outpatient gastrostomy tube placement
- Prophylactic hyperthermic intraperitoneal chemotherapy in gastric cancer
- NCDB trends in young women with metastatic breast cancer diagnosis since screening guideline changes were instituted
- Managing postoperative pain while limiting opioid prescriptions
- New trial aims to settle debate on the intensity of pancreatic cyst surveillance
- Trends in perioperative treatment of gastric cancer 2004–2017: An NCDB analysis
- Virtual acute care for older patients reduces hospital length of stay
- Ga-68 imaging changes clinical management of GI and pancreatic neuroendocrine tumors
- Neoadjuvant and perioperative chemotherapy for localized pancreatic cancer: Leveraging small and large databases in the absence of Level 1 evidence